TAK Operating Cash Flow (Statement)
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Operating Cash Flow (Statement)
TAK Operating Cash Flow (Statement)
Latest reported¥127.62B JPYperiod ending
TAK Quarterly Cash from Operations · JPY (¥52.66B → ¥127.62B)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
TAK operating cash flow (statement) history
Quarterly · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (JPY) |
|---|---|
| 127,623,000,000 | |
| 74,528,000,000 | |
| 373,252,000,000 | |
| 378,228,000,000 | |
| 215,423,000,000 | |
| 222,159,000,000 | |
| 383,756,000,000 | |
| 280,963,000,000 | |
| 170,304,000,000 | |
| 278,588,000,000 | |
| 146,451,000,000 | |
| 198,905,000,000 | |
| 92,400,000,000 | |
| 293,693,000,000 | |
| 378,229,000,000 | |
| 220,993,000,000 | |
| 84,241,000,000 | |
| 375,584,000,000 | |
| 347,510,000,000 | |
| 233,153,000,000 | |
| 166,858,000,000 | |
| 400,960,000,000 | |
| 217,960,000,000 | |
| 246,150,000,000 | |
| 145,861,000,000 | |
| 185,437,000,000 | |
| 143,228,000,000 | |
| 220,298,000,000 | |
| 120,789,000,000 | |
| 117,483,000,000 | |
| 93,162,000,000 | |
| 77,363,000,000 | |
| 40,471,000,000 | |
| 125,746,000,000 | |
| 85,078,000,000 | |
| 92,466,000,000 | |
| 74,564,000,000 | |
| 124,458,000,000 | |
| 25,131,000,000 | |
| 61,004,000,000 | |
| 50,770,000,000 | |
| -145,081,000,000 | |
| 75,600,000,000 | |
| 76,329,000,000 | |
| 18,643,000,000 | |
| 32,981,000,000 | |
| 64,883,000,000 | |
| 72,616,000,000 | |
| 12,037,000,000 | |
| 105,447,000,000 | |
| 43,834,000,000 | |
| 88,422,000,000 | |
| -89,368,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 118,684,000,000 | |
| 59,202,000,000 | |
| 110,156,000,000 | |
| 38,896,000,000 | |
| 112,392,000,000 | |
| 79,337,000,000 | |
| 112,931,000,000 | |
| 76,508,000,000 | |
| 144,464,000,000 | |
| 52,660,000,000 |